Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPlastic/Reconstructive SurgeryPremera Bluecross Breast Surgery Update | OpenPaye…
    Ask Trek AI about this page
    ModifiedPremera BluecrossPolicy N/A

    Reconstructive Breast Surgery and Breast Implant Removal

    Customize your policy alerts

    Sign up for all Premera Bluecross policy alerts

    Know when Premera Bluecross releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Medical-necessity review for reconstructive breast surgery, breast implant explantation, and elective reduction mammaplasty site of service; cosmetic breast surgery is not covered.

    Policy Summary
    PayerPremera Bluecross
    PolicyReconstructive Breast Surgery and Breast Implant Removal
    Policy CodePolicy N/A
    Change TypeCoding update
    Effective DateSeptember 1, 2026
    Last ReviewAug 24, 2026
    Next Review DateN/A
    Key ActionFor explantation, document the original medically necessary, noncosmetic implant indication and at least one qualifying removal condition.
    SourceLink

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    POLICY UPDATE CHANGES

    CPT code 15769 was removed from the policy during the September 1, 2026 interim review.

    30 milesASC access threshold
    III-IVContracture grades supporting removal
    2Implant types addressed
    5-6 yearsInitial silicone-implant imaging
    Insufficient evidencePreventive explantation evidence

    Medical Necessity and Coverage Criteria

    Reduction mammaplasty site of service

    Reduction mammaplasty is reviewed for medical necessity at the site of service.

    Medically necessary hospital outpatient site

    • ASC unavailable or unsuitable: No qualifying ASC within 30 miles can provide the necessary care because the required equipment is unavailable, the physician lacks privileges at an accessible ASC, or an ASC guideline prohibits use because of the individual's health condition or weight.30 miles
    • Concurrent service: The procedure is performed during the same operative session as an additional service that requires a hospital outpatient department.Same operative session
    • Increased complication risk: The individual has a clinical condition that increases the risk of complications, including qualifying anesthesia, cardiovascular, liver, pulmonary, renal, pregnancy, bleeding, transfusion, or obesity risks.

      Examples include ASA III or higher, prolonged surgery greater than 3 hours, MELD score greater than 8, COPD FEV1 less than 50%, moderate-to-severe obstructive sleep apnea, end-stage renal disease on dialysis, BMI at least 50, pregnancy, or anticipated transfusion.

    Reconstructive breast surgery

    Reconstructive breast surgery may be medically necessary when ANY of the following circumstances is met.

    Eligible reconstructive breast surgery

    • Qualifying prior mastectomy or partial mastectomy: The mastectomy or partial mastectomy treated breast cancer, severe fibrocystic breast disease unresponsive to medical therapy, Poland syndrome, breast injury or trauma, or reduced the risk of breast cancer through prophylactic mastectomy.
    • Poland syndrome findings: Poland syndrome is determined by clinical examination or imaging and all three specified findings are present.3 required findings

      Findings: congenital absence or hypoplasia of the pectoralis major and/or minor muscles; breast hypoplasia; and congenital partial absence of the upper costal cartilages of the ribs.

    • Restoration of symmetry: Reconstruction is intended to restore symmetry between the unaffected breast and the affected breast.

    Medically necessary breast implant explantation

    Explantation of a breast implant may be medically necessary only when the original implant was placed for a medically necessary reconstructive purpose and at least one qualifying condition is present.

    Medically necessary explantation

    • Qualifying original placement: The original implant was placed for medically necessary reconstructive purposes, not cosmetic purposes.
    • Qualifying removal condition: At least one of the following is present: Baker class III or IV contracture; documented rupture after medically necessary mastectomy or partial mastectomy due to illness, injury, or disease; extrusion; infection; BIA-ALCL; or surgical treatment of breast cancer or another breast malignancy involving the breast.At least 1 condition

    Reconstructive breast surgery

    Reconstructive breast surgery is medically supported when performed to restore breast appearance or function after a qualifying medical condition or event.

    Qualifying indication: The breast abnormality follows mastectomy, other breast surgery, accidental injury, trauma, congenital abnormality, infection, tumor, or disease.

    Breast reconstruction after mastectomy may include reconstruction of the affected breast, surgery on the opposite breast for symmetry, prostheses, and treatment of physical complications including lymphedema under applicable law or mandate.

    Medically necessary implant explantation

    Implant explantation is medically supported when the implant type, original indication, and current complication or treatment context are documented.

    Required implant information: Document the original indication for implantation and identify the implant as saline-filled or silicone gel-filled.

    Current local or systemic symptoms must also be documented.

    Qualifying explantation indication: The patient has documented implant rupture, infection, extrusion, Baker contracture, or surgical treatment of breast cancer.

    Medical necessity depends on the implant type, indication for removal, and original indication for implantation. Pain alone is not an adequate indication; pain should be related to the Baker classification or a diagnosis of rupture.

    Preventive explantation for BIA-ALCL risk

    Preventive explantation to reduce remote BIA-ALCL risk is not supported when the patient is asymptomatic and has no documented implant complication or breast-cancer surgical context.

    Insufficient-evidence scenario: The patient is asymptomatic and has no documented implant rupture, infection, extrusion, Baker contracture, or surgical treatment of breast cancer.

    The evidence is insufficient to determine that preventive explantation improves the net health outcome, and explantation surgery has known risks.

    BIA-ALCL treatment

    Confirmed BIA-ALCL requires disease-directed surgical management based on multidisciplinary evaluation.

    Confirmed BIA-ALCL management: BIA-ALCL is confirmed by aspiration of an affected fluid collection with CD30 immunohistochemistry and flow cytometry, followed by histologic confirmation.

    Treatment may include bilateral total capsulectomy and implant removal. When appropriate as part of a multidisciplinary evaluation, an en bloc capsulectomy with resection of associated masses and excision of involved lymph nodes is recommended. Contralateral textured implant explantation is recommended in confirmed BIA-ALCL because of possible occult bilateral disease.

    Cosmetic breast surgery performed solely to change breast shape or size for appearance is not covered. Coverage is distinguished from reconstructive surgery addressing a medical condition, such as cancer, trauma, or another qualifying breast abnormality.

    Removal of implants placed for cosmetic purposes is not covered solely for Baker class III contracture, pain unrelated to contracture or rupture, patient anxiety, rupture of a cosmetic saline implant, or systemic symptoms attributed to connective-tissue or autoimmune disease.

    For the elective surgical procedure addressed by the site-of-service criteria, an inpatient hospital or medical-center setting is not medically necessary when the applicable site-of-service criteria are not met.

    Pain alone is an inadequate indication for explantation. The pain must be related to a Baker classification finding or a documented implant rupture.

    Preventive explantation solely to reduce the remote risk of BIA-ALCL is not supported for an asymptomatic individual without a documented implant complication or breast-cancer surgical indication. The evidence is insufficient to show that removal improves the net health outcome, and explantation carries known surgical risks.

    Surgery intended to alter or enhance the appearance of an otherwise unaffected breast is cosmetic rather than reconstructive. This includes correction of congenital breast appearance, such as tubular breasts, when the breast has not been affected by surgery, injury, trauma, or another qualifying medical condition.

    Removal of implants placed for cosmetic purposes is not medically necessary for Baker class III contracture, pain unrelated to contracture or rupture, patient anxiety, rupture of a cosmetic saline implant, or systemic symptoms attributed to connective-tissue or autoimmune disease.

    On-campus outpatient and inpatient hospital or medical-center sites are not medically necessary for the elective surgical procedure when the stated site-of-service criteria are not satisfied.

    Preventive breast implant removal for remote BIA-ALCL risk reduction is not supported when there is no documented rupture, infection, extrusion, Baker contracture, or surgical treatment of breast cancer.

    Explantation based only on pain is not supported. A related Baker classification finding or documented implant rupture is required for pain to support the indication.

    Coding and Site-of-Service Thresholds

    CPTCPT
    11920Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.0 sq. cm or less.
    11921Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.1 to 20.0 sq cm.
    11922Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; each additional 20.0 sq cm, or part thereof; list separately in addition to code for primary procedure.
    11970Replacement of tissue expander with permanent implant.
    11971Removal of tissue expander without insertion of implant.
    15771Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs; 50 cc or less injectate.
    15772Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs; each additional 50 cc injectate, or part thereof; list separately in addition to code for primary procedure.
    19316Mastopexy.
    19318Breast reduction.
    19325Breast augmentation with implant.
    1–10 of 12
    1/2
    HCPCSHCPCS
    C1789Prosthesis, breast (implantable).
    L8600Implantable breast prosthesis, silicone or equal.
    Removed CPT codeCPT
    15769CPT code removed from the policy; procedure description is not provided in this window.
    ASC access distance
    ASC access thresholdNo qualifying ASC within 30 miles can provide the necessary care.
    Eligible access limitationThe ASC may lack necessary equipment or may not be geographically accessible.
    Other access limitationsThe physician may lack privileges at an accessible ASC, or an ASC guideline may prohibit use because of the individual’s health condition or weight.
    Prolonged surgery
    Prolonged surgery thresholdGreater than 3 hours.
    Risk categoryAnesthesia risk.

    Documentation and Review Submission Requirements

    Documentation Required

    Document Qualifying Reconstructive Indication

    For reconstructive breast surgery, submit documentation showing that a prior mastectomy or partial mastectomy was performed and that reconstruction is intended to restore symmetry between the affected and unaffected breasts.

    • Qualifying reasons include treatment of breast cancer; severe fibrocystic breast disease unresponsive to medical therapy; Poland syndrome meeting all specified clinical or imaging findings; breast injury or trauma; or prophylactic mastectomy to reduce breast cancer risk.
    Documentation Required

    Document Medically Necessary Explantation

    For explantation, document that the original implant was placed for a medically necessary, noncosmetic indication and identify the current qualifying condition supporting removal.

    • Qualifying conditions include Baker class III or IV contracture, documented rupture after medically necessary mastectomy or partial mastectomy, extrusion, infection, surgical treatment of breast cancer or other breast malignancy, or BIA-ALCL.

    Clinical Background

    Breast reconstruction recreates a breast after all or part of the breast has been removed, most commonly following mastectomy for cancer, but also after accident, injury, or another qualifying medical condition. Its goal is to restore a breast that matches the shape and size of the unaffected breast. Reconstruction is distinguished from cosmetic surgery performed solely to alter the appearance of an unaffected breast.

    Policy Definitions and Classifications

    ASA Physical Status Classification
    ASA IA normal healthy patient.
    ASA IIA patient with mild systemic disease.
    ASA IIIA patient with severe systemic disease, substantive functional limitations, or one or more moderate-to-severe diseases.
    ASA IVA patient with severe systemic disease that is a constant threat to life.
    Baker Classification
    Baker grade IThe augmented breast feels as soft as a normal breast.
    Baker grade II
    Policy Summary
    PayerPremera Bluecross
    PolicyReconstructive Breast Surgery and Breast Implant Removal
    Policy CodePolicy N/A
    Change TypeCoding update
    Effective DateSeptember 1, 2026
    Last ReviewAug 24, 2026
    Next Review DateN/A
    Key ActionFor explantation, document the original medically necessary, noncosmetic implant indication and at least one qualifying removal condition.
    SourceLink
    On This Page
    Medical Necessity and Coverage CriteriaCoding and Site-of-Service ThresholdsDocumentation and Review Submission RequirementsClinical BackgroundPolicy Definitions and Classifications
    Site-of-service relevanceA prolonged procedure greater than 3 hours may support hospital outpatient site-of-service medical necessity when it increases complication risk.
    Recent myocardial infarction
    Recent myocardial infarction thresholdLess than 3 months.
    Risk categoryCardiovascular risk.
    Site-of-service relevanceA recent myocardial infarction may support hospital outpatient site-of-service medical necessity when it increases complication risk.
    Recent cerebrovascular accident
    Recent cerebrovascular accident thresholdLess than 3 months.
    Risk categoryCardiovascular risk.
    Site-of-service relevanceA recent cerebrovascular accident may support hospital outpatient site-of-service medical necessity when it increases complication risk.
    Drug-eluting stent
    Drug-eluting stent thresholdPlaced less than 1 year ago.
    Risk categoryIncreased risk for cardiac ischemia.
    Site-of-service relevanceA drug-eluting stent placed less than 1 year ago may support hospital outpatient site-of-service medical necessity.
    Angioplasty
    Angioplasty thresholdPerformed less than 90 days ago.
    Risk categoryIncreased risk for cardiac ischemia.
    Site-of-service relevanceAngioplasty performed less than 90 days ago may support hospital outpatient site-of-service medical necessity.
    MELD score
    MELD score thresholdGreater than 8.
    Risk categoryAdvanced liver disease.
    Site-of-service relevanceAn MELD score greater than 8 may support hospital outpatient site-of-service medical necessity when it increases complication risk.
    COPD FEV1
    COPD FEV1 thresholdLess than 50%.
    Risk categoryPulmonary risk.
    Site-of-service relevanceCOPD with an FEV1 less than 50% may support hospital outpatient site-of-service medical necessity.
    Poorly controlled asthma FEV1
    Poorly controlled asthma thresholdFEV1 less than 80% despite treatment.
    Risk categoryPulmonary risk.
    Site-of-service relevancePoorly controlled asthma meeting this FEV1 threshold may support hospital outpatient site-of-service medical necessity.
    Obstructive sleep apnea
    Moderate obstructive sleep apneaApnea-hypopnea index (AHI) greater than or equal to 15 and less than or equal to 30.
    Severe obstructive sleep apneaAHI greater than or equal to 30.
    Risk categoryModerate to severe obstructive sleep apnea is a qualifying increased-complication-risk condition.
    Morbid obesity
    Morbid obesity thresholdBody mass index (BMI) greater than or equal to 50.
    Risk categoryOther increased-complication-risk condition.
    Site-of-service relevanceMorbid obesity at this threshold may support hospital outpatient site-of-service medical necessity.
    Poorly controlled resistant hypertension
    Resistant hypertension thresholdThree or more drugs are required to control blood pressure.
    Risk categoryCardiovascular risk.
    Site-of-service relevancePoorly controlled resistant hypertension meeting this threshold may support hospital outpatient site-of-service medical necessity.
    Documentation Required

    Support Hospital Site of Service

    Support the requested hospital site of service with documentation showing why an ambulatory surgical center (ASC) is unavailable or inappropriate, or why the patient requires a hospital setting.

    • A hospital outpatient setting may be justified when no qualifying ASC within 30 miles has the necessary equipment, the physician lacks privileges at an accessible ASC, or the ASC prohibits the procedure because of the patient’s health condition or weight.
    • Also document concurrent procedures requiring a hospital outpatient department in the same operative session or a qualifying increased-risk condition, such as ASA III or higher, major cardiovascular or pulmonary risk, end-stage renal disease, pregnancy, bleeding disorder requiring replacement products, anticipated transfusion, or BMI ≥50.
    Documentation Required

    Document Implant History and Current Symptoms

    For implant removal review, document the original indication for implantation, whether the implant is saline or silicone gel-filled, and the patient’s current local or systemic symptoms and relevant examination findings.

    • Include the implant history and findings relevant to contracture, rupture, infection, extrusion, malignancy, or other qualifying conditions.
    Documentation Required

    Document Rupture Imaging

    Document suspected or confirmed rupture with an imaging study and describe any persistent localized symptoms when imaging is negative or unavailable.

    • Submit mammography, magnetic resonance imaging, or ultrasonography as applicable.
    • Lack of imaging confirmation in association with persistent local symptoms is reviewed case by case.
    Documentation Required

    Use Presentation-Appropriate Imaging

    Select initial imaging based on symptoms, implant type, patient age, and time since implantation; document the clinical presentation and rationale for the modality ordered.

    • For suspected saline implant rupture: ultrasound is usually appropriate under age 40; at age 40 or older, diagnostic digital breast tomosynthesis or diagnostic mammography is usually appropriate, as alternatives.
    • For silicone implants: in asymptomatic patients, initial imaging is usually not appropriate before 5 years; at 5–6 years, ultrasound or noncontrast breast MRI is usually appropriate, with follow-up every 2–3 years after a negative study.
    • For suspected silicone implant complication in a patient younger than 30, noncontrast breast MRI is usually appropriate; the panel did not agree on ultrasound.
    Documentation Required

    Evaluate Suspected BIA-ALCL

    When BIA-ALCL is suspected, evaluate any peri-implant fluid collection by aspiration and submit the specimen for CD30 immunohistochemistry and flow cytometry, followed by histologic confirmation as appropriate.

    • BIA-ALCL may present with a seroma, effusion, or breast swelling around the scar capsule and has been reported with saline or silicone textured implants.
    • There is no recommended screening for asymptomatic individuals without symptoms.
    Denial Risk

    Identify Cosmetic Intent or Cosmetic Implant Complication

    Breast reconstruction to change breast shape or size solely for appearance is cosmetic and not covered. Removal of implants placed for cosmetic purposes is covered only when interval breast cancer, BIA-ALCL, or other breast disease requires mastectomy or partial mastectomy.

    • Absent a qualifying breast disease, subsequent removal of cosmetic implants is generally considered a complication of a non-covered service and is contractually excluded; review the member contract.
    Denial Risk

    Flag Unjustified Hospital Site of Service

    Flag on-campus outpatient or inpatient hospital site of service as not medically necessary when the applicable ASC-access, concurrent-procedure, or patient-risk exception is not documented.

    • The hospital setting must be the most appropriate, safe, and cost-effective site for the elective procedure.
    • Inpatient hospital or medical center service is not medically necessary when the site-of-service criteria are not met.
    Denial Risk

    Flag Unsupported Explantation Indication

    Do not support explantation based only on an unsupported indication. Baker class III contracture in a cosmetic implant, unrelated pain, patient anxiety, cosmetic saline implant rupture, or systemic symptoms attributed to connective-tissue or autoimmune disease are not medically necessary indications under this policy.

    • Confirm a medically necessary original implant indication and a qualifying current condition before submitting for coverage.
    Denial Risk

    Assess Complication of Non-Covered Cosmetic Service

    When implants were placed for cosmetic purposes, removal prompted by a condition that does not require mastectomy or partial mastectomy is generally treated as a complication of a non-covered service and is contractually excluded in most cases.

    • Review the member contract for any coverage applicable to complications of non-covered procedures.
    Denial Risk

    Pain Alone Is Insufficient

    Pain alone is an inadequate indication for explantation. Relate the pain to a documented Baker classification finding or to a diagnosis of implant rupture.

    • Do not rely on isolated pain without a related contracture finding or documented rupture.
    Denial Risk

    Rupture Not Confirmed

    Do not treat suspected rupture as confirmed without appropriate imaging or documented persistent localized symptoms supporting case-by-case review.

    • Submit mammography, MRI, or ultrasonography when available.
    • If imaging is negative or not confirmatory, document the persistent localized symptoms and clinical rationale for review.
    Denial Risk

    Prophylactic Explantation Without a Complication

    Asymptomatic preventive explantation is unsupported when there is no documented rupture, infection, extrusion, Baker contracture, or breast-cancer treatment. Evidence is insufficient to show that preventive removal reduces BIA-ALCL risk, and explantation carries surgical risk.

    • Document a qualifying complication or malignancy before requesting coverage.
    • Consensus statements may support shared decision-making for selected textured implants, but reasonableness does not by itself establish coverage or medical necessity.
    The breast is less soft, and the implant can be palpated but is not visible.
    Baker grade IIIThe breast is firm and palpable, and the implant or its distortion is visible.
    Baker grade IVThe breast is hard, painful, cold, tender, and distorted.
    Cosmetic
    Cosmetic servicesServices primarily intended to preserve or improve appearance.
    Cosmetic surgerySurgery performed to reshape structures of the body.
    Primary purposeThe purpose is to improve the patient’s appearance or self-esteem.
    Cosmetic
    Appearance-focused careCosmetic services are primarily intended to preserve or improve appearance.
    Reshaping procedureCosmetic surgery reshapes structures of the body.
    Intended outcomeThe intended outcome is improvement of the patient’s appearance or self-esteem.
    Physical functional impairment
    DefinitionA limitation from normal or baseline physical functioning.
    ExamplesIt may include problems with ambulation, mobilization, communication, respiration, eating, swallowing, vision, facial expression, skin integrity, distortion of nearby body parts, or obstruction of an orifice.
    Excluded impairmentsSocial, emotional, and psychological impairments or potential impairments are excluded.
    Reconstructive surgery
    DefinitionSurgery performed on abnormal body structures caused by congenital defects, developmental abnormalities, trauma, infection, tumors, or disease.
    General purposeReconstructive surgery is generally performed to improve function.
    Qualifying causesThe abnormality may result from a congenital defect, developmental abnormality, trauma, infection, tumor, or disease.
    Reconstructive breast surgery
    DefinitionA surgical procedure designed to restore the normal appearance of the breast after surgery, accidental injury, or trauma.
    Medical contextReconstructive breast surgery is distinguished from purely cosmetic procedures by the presence of a medical condition, such as breast cancer or trauma.
    Common indicationThe most common indication is a prior mastectomy.
    Baker Classification
    Baker grade IThe breast feels as soft as normal.
    Baker grade IIThe breast is less soft, and the implant is palpable but not visible.
    Baker grade IIIThe breast is firm and palpable, and the implant or distortion is visible.
    Baker grade IVThe breast is hard, painful, cold, tender, and distorted.
    BIA-ALCL
    DefinitionA rare T-cell lymphoma that can develop around textured breast implants in the breast area.
    Cancer distinctionBIA-ALCL is not breast cancer.
    Typical presentationIt commonly presents as a seroma or effusion with swelling of the breast surrounding the scar capsule.